Abstract: Methods for addressing sigma receptor affinity and activity have been explored and although several protocols have been employed, only few procedures resulted reliable. Sigma-1 receptor affinity protocol using guinea-pig brain and (+)-[
SIGMA RECEPTORS IN TUMOR CELL LINES
Sigma receptors are endocellular proteins present in different tissues and they are overexpressed in many tumors [1] . In the last years, sigma receptors have been recognized in several tumor cell lines with different protein expression level. In detail, sigma-1 subtypes are highly expressed in human SH-SY5Y neuroblastoma cell line [2, 3] , human NCI-H1299 lung tumor cells [4] and in Caco-2 cell line [5] . Sigma-2 subtypes are highly expressed in SKBr3 and in MCF7/Adr breast adenocarcinoma [6] . Both receptor subtypes are overexpressed in LNCaP, FGC prostate carcinoma, in human SK-N-SH neuroblastoma [1, 7] and in EMT-6 mammary carcinoma [8] .
The overexpression of these receptors in the above mentioned cell lines has been pointed out by saturation binding assay with radioligand, (+)- [ 3 H]-pentazocine for sigma-1 and [
3 H]-DTG for sigma-2 receptors.
Although several classes of sigma ligands have been developed and a pharmacophoric model for sigma-1 subtype has been provided [9] , different in vitro biological methods are employed so that it is hard to compare biological results from different assays. Indeed, the first controversial aspect regards the competition binding assay with radioligand because of several protocols employed differing in tissue and radioligand. Almost all binding protocols reported guineapig brain and (+)- [ 3 H]-pentazocine for sigma-1 subtype and rat liver and [
3 H]-DTG for sigma-2 subtype [10] [11] [12] . Another critical aspect involved the activity evaluation of tested compounds. Since selective sigma-1 and sigma-2 ligands are *Address correspondence to this author at the Dipartimento Farmacochimico, Facoltà di Farmacia, Università degli Studi di Bari, via Orabona 4, 70125, Bari, Italy; E-mail: colabufo@farmchim.uniba.it available only from short time, the pathway of each receptor subtype inducing cell death are in progress. Consequently, it was very difficult to establish a correlation between the observed effect and the intrinsic activity of tested compounds. In the last years several attempts have been performed to point out a method for characterizing the sigma-1 and sigma-2 receptors pathway [13, 14] .
Sigma Receptors in SK-N-SH and in C6 Cell Lines
In the last decade, our group developed an in vitro method to characterize sigma receptors pathways employing two tumor cell lines: human SK-N-SH neuroblastoma cells with high sigma-2 receptors expression whereas sigma-1 receptors were in low affinity state and rat C6 glioma where sigma-1 receptors displayed a receptor density higher than sigma-2 subtypes [15] . Sigma receptor density found in both cell lines were determined by saturation analysis with radioligand and the corresponding plots are reported in Fig. (1) .
This different receptor distribution permitted to study sigma-2 receptor activity of selected compounds in SK-N-SH cells and sigma-1 receptor activity in C6 cells. Indeed, several standard compounds have been tested such as "claimed" sigma-1 receptor agonist (+)-pentazocine and AC915, sigma-1 receptor antagonist NE100, sigma-2 receptor agonists DTG and PB28 and sigma-2 receptor antagonist AC927 (Fig. 2) [16] .
Moreover, haloperidol has been tested because it was active towards both receptors. These ligands have been evaluated by competition binding assay in both cell lines finding superimposed affinity values obtained by standard protocol as listed in Table 1 .
In SK-N-SH cells, DTG, PB28 and haloperidol showed cytotoxic and antiproliferative effects and these effects re- flected their sigma-2 receptors affinity. The cytotoxicity has been monitored by Lactate DeHydrogenase (LDH) detection assay because LDH can be recognized after 24 h treatment in the medium out of the cells when the cell membranes are damaged. Moreover, the antiproliferative effect has been monitored by MTT assay. Cell viability has been detected by this assay after 48 h treatment with tested compounds (Table  2 ) and the pathway involved in these effects has been found caspase-independent [15] . By contrast, other authors found a different sigma-2 receptors pathway caspase-activated [6, [18] [19] [20] .
These effects, determined in the presence of compounds above mentioned, are reversed by purported sigma-2 antagonist AC927, demonstrating that the effect of compounds is sigma-2 receptors-mediated [15] .
Purported sigma-1 receptor antagonist NE100 displayed in C6 cells cytotoxic and antiproliferative effects determined in the same experimental conditions. These effects were reverted by (+)-pentazocine, showing that NE100 activity is sigma-1 receptors-mediated [15] . Although these methods represent an important guide to address sigma-1 and sigma-2 receptors activity, the findings, carried out in biological systems such as tumor cell lines, are related to the pathological role of these receptors but not to their physiological involvement.
SIGMA RECEPTORS ACTIVITY IN EX VIVO ASSAY
In order to investigate sigma-1 and sigma-2 receptors physiological role, our group determined their presence in two contractile tissues, guinea-pig ileum and bladder, by saturation binding analysis with radioligand determining a basal expression level of both receptors (Fig. 3) .
The biological samples were electrically stimulated and a stable contraction of the tissue was recorded. Since sigma-1 and sigma-2 receptors are localized in guinea-pig ileum and bladder at prejunctional level [13, 16] , their functional involvement by electrical field stimulation was studied. Therefore, a contractile response was recorded and the activation of receptors localized at prejunctional level, such as sigma subtypes, could decrease the electrically evoked contractions in ileum and bladder. 6.51 ± 0.08 6.35 ± 0.03 5.09 ± 0.03 4.82 ± 0.06 AC927 HCl no effect no effect no effect no effect Starting from this plan, we investigated the ability of sigma-1 and sigma-2 ligands to inhibit the electrically evoked contractions (Fig. 4) . The biological activity values (EC 50 ) are listed for each sample in Table 3 [16] .
Both sigma-1 and sigma-2 receptor ligands have been tested selecting agonists and antagonists in order to establish their effect. Moreover, in this biological assay sigma-1 subtypes contribution has been counteracted by receptors desensitization in the presence of (+)-pentazocine (Fig. 5) . This procedure is suitable for GPCR receptors and it determined the receptor uncoupling from its transduction signal. This procedure is carried out by tissue exposure to the selective sigma-1 agonist (+)-pentazocine to lead the receptor in unresponsive state. In these experimental conditions, the receptor binds the ligand but it is unable to activate the transductional pathway.
Both in bladder and ileum the best results have been obtained for sigma-2 receptor agonists PB28 (EC 50 = 5.80 M and 3.78 M, respectively) and DTG (EC 50 = 12.7 M and 6.60 M, respectively) and sigma-1 antagonist NE100 (EC 50 = 24.3 M and 9.04 M, respectively), while sigma-1 agonists such as (+)-pentazocine and AC915 were found inactive. In the desensitized samples also NE100 failed to modulate contraction while sigma-2 agonists PB28 (EC 50 = 2.62 M and 3.96 M, respectively) and DTG (EC 50 = 6.90 M and 12.5 M, respectively) were again the most active agents. Haloperidol, because of its sigma-1 antagonist and sigma-2 agonist activity, displayed high contraction modulation in non desensitized assay (EC 50 = 10.9 M and 5.90 M, respectively) and superimposed activity in the corresponding desensitized sample (EC 50 = 8.90 M and 10.7 M, respectively), confirming its dual sigma-2 agonist and sigma-1 antagonist activity [16] .
Then, in guinea-pig ileum, sigma receptors postjunctional activation has been also investigated by carbachol stimulation. This muscarinic agonist induced a contraction dosedependently and the effect of sigma-2 agonists on these contractions has been evaluated. In particular, PB28 reduced the carbachol-induced contractions by a non competitive manner (Fig. 6) [21] .
This finding can be explained by two mechanisms: 1) PB28 can interact with the muscarinic receptor on an accessory site; 2) PB28 can interfere in the cellular response between the activation of the muscarinic receptor and contraction, such as the rise of intracellular Ca 2+ concentration ([Ca   2+ ] i ). Moreover, other authors have previously reported that sigma-2 agonists increase [Ca 2+ ] i in SK-N-SH cells [7] .
Since human SK-N-SH neuroblastoma cells overexpressed sigma-2 receptors whereas sigma-1 receptors were present in low affinity state, we chose again this cell line to investigate the intracellular pathway linked to sigma-2 receptors activation [15] .
Previously, several sigma ligands have been tested in neuroblastoma cells and the results demonstrated that these compounds produced two time-dependent increases of intracellular [Ca 2+ ] i : a rapid transient release of Ca 2+ from the endoplasmic reticulum and a latent and sustained rise after prolonged exposure to sigma-receptor ligands [7] . Starting from these findings, in order to investigate the involvement of sigma receptors on Ca 2+ homeostasis, we tested the best sigma-2 compound, PB28, in the same cell line and it did not affect the intracellular Ca 2+ concentration (Fig. 7A) . Then, Ca 2+ mobilization after stimulation with carbachol or thapsigargin was characterized (Fig. 7B) [21] . The Ca 2+ rise after carbachol stimulation was not observed when cells were preincubated for 45 min with PB28 (Fig. 7C) while the addition of thapsigargin, a specific inhibitor of Sarco Endoplasmic Reticulum Ca 2+ ATPase (SERCA), after the challenge with carbachol, increased the [Ca 2+ ] i (Fig. 7C) . In the same experimental conditions, PB28 also abolished the Ca 2+ response elicited by histamine (data not shown), suggesting that PB28 inhibits one of the intracellular Ca 2+ mobilization pathway linked to GPCR activation. These results suggest that PB28 per se does not directly influence [Ca 2+ ] i but it modulates the Ca 2+ response to physiological agonists (carbachol and histamine). This hypothesis is supported by the direct stimulation of InsP 3 receptors with its endogenous ligand, InsP 3 , in the absence and in the presence of PB28 (Fig. 8) .
The results demonstrated that PB28 abolished InsP 3 -mediated response. These findings suggested that in SK-N-SH sigma-2 receptor could be a InsP 3 receptor region or could directly interact with this receptor.
SIGMA-2 RECEPTORS CHARACTERIZATION
Since human SK-N-SH neuroblastoma is a specific biological matrix for sigma-2 receptors [15, 22] and PB28 is the most potent and selective sigma-2 receptor agonist [16] , we planned an affinity chromatography strategy to isolate the receptor [23] . Considering that PB28 did not have the structural requirements to couple the stationary phase, we remod- eled it introducing an amino group on the aromatic ring to link the column-packed stationary phase by covalent bond (Scheme 1).
The amino group was inserted on the tetralin moiety in para position with respect to methoxy substituent because previous Structure AFfinity Relationship (SAFIR) studies demonstrated that the presence of substituents in this position did not affect sigma-2 receptor affinity and activity. The linkage of aminoderivative to the stationary phase caused the production of N-hydroxysuccinimide (NHS) as leaving group. Human SK-N-SH neuroblastoma protein suspension was eluted across the modified stationary phase and by elution through the column several proteins were separated. The eluted proteins were analyzed by SDS-PAGE gel electrophoresis, and the stained bands (Fig. 9A) were characterized by MALDI-MS and LC-MS-MS analyses.
The identification of proteins binding activated stationary phase has been performed by spectroscopy and the identified peptides are listed in Table 4 .
In parallel we eluted the crude proteins through an uncoupled column using buffers with different pH (7.4 and 3.0) for estimating the possible interaction between the uncoupled stationary phase and the proteins. At pH 3.0, the bands with apparent molecular weight 13 kDa and 34 kDa were eluted by the uncoupled stationary phase (Fig. 9B) . Consequently, these aspecific binding proteins were also eluted together with specific binding proteins by the coupled stationary phase. For this reason, the proteins having an apparent mobility of 13 kDa and 34 kDa were considered nonspecific bands.
The bands 15A, 15B, and 15C, characterized by MALDI-MS, matched H3.3A, H2B, and H2A.5 human histones, respectively. The bands 32A and 32B were analyzed by LC-MS-MS because of the comigration of several proteins, and band 32B was constituted by two different proteins, human H1.2 histone and 40S ribosomal protein S3. The human histones are basic proteins classified in H1, H2A, H2B, H3, and H4 subtypes. H1 subtype is not involved in the octameric structure of nucleosoma, which is constituted by two units of each histone because it is interposed between two nucleosoma, easing their packing. The acetylation and deacety- lation of hystone proteins by histone acetylases (HATs) and deacetylases (HDACs) influenced DNA accessibility to factors regulating replication, repair, and transcription [24, 25] . To corroborate PB28 interaction with nuclear proteins, we prepared the nuclear fraction by lysing neuroblastoma cells since the histones are the major protein component of chromatin. In the nuclear fraction we performed saturation binding analysis with radioligand, finding [ 3 H]-DTG K d value (18.2 nM) comparable to the corresponding value found in the crude proteins (21.0 nM) [15] .
Thus, two different hypotheses have been suggested: 1) sigma-2 receptors match histone proteins; 2) sigma-2 ligand PB28 binds both histone proteins and sigma-2 receptors. Sigma-2 receptors overexpression in tumor tissues can be However, the hypothesis of histones identification disagree with the results found by Bowen et al. [12] that identified sigma-2 receptors in lipid rafts using the raft marker protein, flotillin-2.
Finally, 40S ribosomal protein S3 (rpS3) in the 32B band protein as comigrating with H1.2 histone poorly contributed to the corroboration of our hypotheses. The enigma related to sigma-2 receptor isolation and characterization could be elucidated using sigma-2 selector ligands having different structural properties from that of our aminoderivative (Scheme 1). In this way, the histones that we isolated and identified, could be confirmed to be actually sigma-2 receptor proteins.
THE UPREGULATION OF SIGMA-2 RECEPTORS IN BOVINE UROTHELIAL CANCERS: A POSSIBLE AUTOPHAGIC PATHWAYS INVOLVEMENT
Sigma-2 receptors have not been investigated in veterinary oncogenesis. Recently, the first study about sigma-2 receptor expression was carried out on the spontaneous urothelial cancer of cattle grazing on pasturelands rich in bracken fern [26] . In cattle, bovine papillomavirus type 2 (BPV-2) plays a central role in oncogenetic mechanisms leading to urothelial cancers. It seems act synergistically with ptaquiloside, the DNA-reactive major toxin of bracken. In all neoplastic lesions the presence of BPV-2DNA was detected by PCR; in addition, E5 protein, believed to be the most important viral oncoprotein, was detected by immunoprecipitation. The lesions were classified according to the criteria reported in the recent World Health Organization (WHO) Blue Book about the pathology and genetics of tumors of the urinary system and male genital organs in humans [27, 28] as the WHO histological classification appears to encompass all microscopic patterns of the urinary bladder tumors observed in cattle [29] . Criteria we used were validated by morphometric studies. Therefore, urothelial carcinomas were divided in papillary and invasive carcinomas; both of them were graded in low and high grade carcinomas. Morphometric parameters were correlated with grading of tumors. So, mean nuclear area and mean nuclear perimeter of low grade carcinomas were lower than the parameters observed in high grade carcinomas. In all the carcinomas examined, morphometry allowed us to validate histopathologic investigation [30] . Low and high grade papillary and invasive carcinomas were differentially characterized by an upregulation of sigma-2 receptors. The higher grade of tumors matched the more sigma-2 receptors upregulated tissue. Therefore, as in humans, sigma-2 expression appears to be correlated to grading of bovine urothelial tumors.
It is generally accepted that sigma-2 receptors are involved in the programmed cell death (PCD) type I or apoptosis of cancer cells. However, some molecular finding we found in our samples allow us to put forward a working hypothesis.
In the same samples of bovine urothelial tumors in which we detected the upregulation of sigma-2 receptors, we also found the overexpression of the Ferritin Heavy Chain (FHC) [30] and the Bag-3 protein. Both FHC and Bag-3 protein are known to be powerful anti-apoptotic factors thus playing an important role in cancer cell survival [31, 32] . We speculate sigma-2 receptors may be also involved in tumor cell survival pathways via autophagy machinery thus acting as a double-edged sword. The mechanisms that regulate the survival-supporting and death-promoting role for autophagy are still far from resolution. Recently, it has been shown that siramesine, a sigma-2 receptor ligand, responsible for PCD via lysosomal leakage and oxidative stress can also induce cytoprotective autophagosomes accumulation [33] . It seems to be a threshold limit at which autophagosomes formation can counteract the death induced by lysosomal leakage [34] . Finally, some experimental data of ours appear to support this theory. We were able to show that sigma-2 receptor agonists are responsible for the upregulation of Toll-Like Receptor 4 (TLR4) in human colon tumor Caco-2 cell line and macrophage U937 cell line (data not shown). TLR4 expression is increased in human bladder cancer T24 cell line [35] and it has been reported a positive correlation between the expression of TLR4 and cell malignancy [36] . It has been shown that TLR4 induces the expression of the antiapoptotic receptor B7-H1 in bladder cancer cells [37, 38] . It is reasonable to believe bona fide that TLR4 may also be involved in autophagy mechanisms of bovine cancer cells thus contributing to their survival. More speculatively, we don't exclude that autophagy may be involved in a protective role against viral infection since urothelial cancers of the urinary bladder in cattle are associated with papillomavirus type 2 infection. Recently, it has been shown that TLR4 serves as a previously unrecognized sensor for autophagy associated with innate and adaptive immunity [39] . It is worthy remembering that autophagy is now emerging as a central pathway that can participate in trafficking events that activate innate and adaptive immune responses to viruses, bacteria and parasites [39] [40] [41] .
CONCLUSIONS AND PERSPECTIVES
A great interest is involving sigma receptors both because they are considered a novel target for new antineoplastic agents and because they have been characterized as specific biomarkers in several tumor cells. To hit the first aim it is needed to establish the intrinsic activity of each ligand since only sigma-2 agonist and/or sigma-1 antagonist induce apoptosis in tumor cells. Moreover, for these ligands some pharmacokinetic parameters such as apparent permeability (P app ) and lipophylicity (LogP) should be evaluated to better characterize the pharmacological activity of these compounds. Furthermore, it is very important to plan more selective sigma receptors ligands, towards sigma-2 receptors in particular, to detect the overepression of sigma receptors in tumor cells. For this second aim, sigma ligands bearing a fluorescent probes GFP-like should be designed. On the other hand, sigma ligands having a fluorescent moiety as molecular determinant could be planned to overcome pharmacodynamic and/or pharmacokinetic limitations due to fluorescent probe functionalization. Finally, it is important to know how sigma receptor overexpression is linked to antiapoptotic process of cells progressing to cancer pathology. 
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